Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: who wrote ()	7/9/1996 12:16:00 AM
From: Steve	of 370

Good news for VION today from Dow Jones News: Vion Pharma Gets Patent Notice Of Allowance For Analog Dow Jones News Service ~ July 8, 1996 ~ 2:14 pm EST NEW HAVEN, Conn. (Dow Jones)--Vion Pharmaceuticals Inc. (VION) received a notice of allowance from the Patent and Trademark office covering the composition of matter and method of use for treating hepatitis B virus infection with the B-L-Fd4C nucleoside analog. In a press release, Vion said the compound is one of a series of antiviral compounds that it licenses from Yale University. Vion discovers, develops and commercializes oncology and antiviral products. (END) DOW JONES NEWS 07-08-96 2:14 PM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next